Abstract
Objective: To assess the effect of phytoestrogens on bone turnover and growth in adolescent boys.
Design: Randomized double-blind placebo-controlled trial.
Setting: Single school in northwest Tasmania.
Participants: Adolescent boys (treatment n=69, placebo n=59, mean age 16.8 y).
Interventions: Six weeks of isoflavone supplementation (Novasoy, 50 mg daily of isoflavone equivalents). Bone turnover markers (bone specific alkaline phosphatase (BAP) and pyridinoline creatinine ratio (PYR)) were measured at baseline and follow-up.
Results: Despite marked increases in urinary genistein and daidzein in the treatment arm (both P<0.001), there were no significant differences in BAP, PYR or short-term height or weight change. This applied to both intention-to-treat and per protocol analysis. Neither was there a significant correlation between urinary genistein and daidzein levels and BAP or PYR.
Conclusions: Phytoestrogen supplementation to the level of usual Japanese dietary intake has no measurable effect on bone turnover in adolescent boys. Longer-term studies of bone density may be desirable but it is unlikely that there will be a large effect in either girls or boys given the lower endogenous oestrogen levels in boys.
Sponsorship: National Health and Medical Research Council of Australia, Arthritis Foundation of Australia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alekel, DL, Germain, AS, Peterson, CT, Hanson, KB, Stewart, JW & Toda, T (2000). Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr., 72, 844–852.
Caruso-Nicoletti, M, Cassorla, F, Skerda, M, Ross, JL, Loriaux, DL & Cutler, GB Jr (1985). Short term, low dose estradiol accelerates ulnar growth in boys. J. Clin. Endocrinol. Metab., 61, 896–898.
Dalais, FS, Rice, GE & Wahlqvist, ML (1998). Effects of dietary phytoestrogens in postmenopausal women. Climacteric, 1, 124–129.
Delmas, PD, Hardy, P, Garnero, P & Dain, M (2000). Monitoring individual response to hormone replacement therapy with bone markers. Bone, 26, 553–560.
Draper, CR, Edel, MJ, Dick, IM, Randall, AG, Martin, GB & Prince, RL (1997). Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr., 127, 1795–1799.
Ettinger, B, Black, DM, Mitlak, BH, Knickerbocker, RK, Nickelsen, T, Genant, HK, Christiansen, C, Delmas, PD, Zanchetta, JR, Stakkestad, J, Gluer, CC, Krueger, K, Cohen, FJ, Eckert, S, Ensrud, KE, Avioli, LV, Lips, P & Cummings, SR (1999). Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA, 282, 637–645.
Falahati-Nini, A, Riggs, BL, Atkinson, EJ, O'Fallon, WM, Eastell, R & Khosla, S (2000). Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J. Clin. Invest., 106, 1553–1560.
Fanti, P, Monier-Faugere, MC, Geng, Z, Schmidt, J, Morris, PE, Cohen, D & Malluche, HH (1998). The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int., 8, 274–281.
Ishida, H, Uesugi, T, Hirai, K, Toda, T, Nukaya, H, Yokotsuka, K & Tsuji, K (1998). Preventive effects of the plant isoflavones, daidzein and genistein, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol. Pharm. Bull., 21, 62–66.
Jones, G, Beard, T, Parameswaran, V, Greenaway, T & Von Witt, R (1997). A population-based study of the relationship between salt intake, bone resorption and bone mass. Eur. J. Clin. Nutr., 51, 561–565.
Kimira, M, Arai, Y, Shimoi, K & Watanabe, S (1998). Japanese intake of flavonoids and isoflavonoids from foods. J. Epidemiol., 8, 168–175.
Kuiper, GG, Lemmen, JG, Carlsson, B, Corton, JC, Safe, SH, van der Saag, PT, van der Burg, B & Gustafsson, JA (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252–4263.
Lieuw-A-Fa, M, Sierra, RI & Specker, BL (1995). Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age. J. Bone Miner. Res., 10, 849–853.
Marowska, J, Kobylinska, M, Lukaszkiewicz, J, Talajko, A, Rymkiewicz-Kluczynska, B & Lorenc, RS (1996). Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application. Bone, 19, 669–677.
Morris, NM & Udry, JR (1980). Validation of a self-administered instrument to assess stage of adolescent development. J. Youth Adoles., 9, 271–280.
Picherit, C, Chanteranne, B, Bennetau-Pelissero, C, Davicco, MJ, Lebecque, P, Barlet, JP & Coxam, V (2001). Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat. Br. J. Nutr., 85, 307–316.
Potter, SM, Baum, JA, Teng, H, Stillman, RJ, Shay, NF & Erdman, JW Jr (1998). Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr., 68, 1375S–1379S.
Rauch, F, Schonau, E, Woitge, H, Remer, T & Seibel, M (1994). Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp. Clin. Endocrinol., 102, 94–97.
Schnitzer, T, Bone, HG, Crepaldi, G, Adami, S, MCClung, M, Kiel, D, Felsenberg, D, Recker, RR, Tonino, RP, Roux, C, Pinchera, A, Foldes, AJ, Greenspan, SL, Levine, MA, Emkey, R, Santora, AC Jr, Kaur, A, Thompson, DE, Yates, J & Orloff, JJ (2000). Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging (Milano), 12, 1–12.
Somekawa, Y, Chiguchi, M, Ishibashi, T & Aso, T (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet. Gynecol., 97, 109–115.
Szulc, P, Seeman, E & Delmas, PD (2000). Biochemical measurements of bone turnover in children and adolescents. Osteopor. Int., 11, 281–294.
Tsutsumi, N (1995). Effect of coumestrol on bone metabolism in organ culture. Biol. Pharm. Bull., 18, 1012–1015.
Upmalis, DH, Lobo, R, Bradley, L, Warren, M, Cone, FL & Lamia, CA (2000). Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause, 7, 236–242.
van Dale, PL, Seibel, MJ, Burger, H, Hofman, A, Grobbee, DE, van Leeuwen, JP, Birkenhager, JC & Pols, HA (1996). Case control analysis of bone resorption markers, disability and hip fracture risk: the Rotterdam study. Br. Med. J., 312, 482–483.
Wang, MC, Aguirre, M, Bhudhikanok, GS, Kendall, CG, Kirsch, S, Marcus, R & Bachrach, LK (1997). Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths. J. Bone Miner. Res., 12, 1922–1935.
Wangen, KE, Duncan, AM, Merz-Demlow, BE, Xu, X, Marcus, R, Phipps, WR & Kurzer, MS (2000). Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab., 85, 3043–3048.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jones, G., Dwyer, T., Hynes, K. et al. A randomized controlled trial of phytoestrogen supplementation, growth and bone turnover in adolescent males. Eur J Clin Nutr 57, 324–327 (2003). https://doi.org/10.1038/sj.ejcn.1601544
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601544
Keywords
This article is cited by
-
Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials
European Journal of Clinical Nutrition (2008)
-
Vitamin D insufficiency in adolescent males in Southern Tasmania: prevalence, determinants, and relationship to bone turnover markers
Osteoporosis International (2005)